Immunome, Inc. · NASDAQ:IMNM
The Vanguard Group's stake in Immunome, Inc. fell to 4.81% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 30, 2025
The Vanguard Group's stake in Immunome, Inc. fell to 4.81%, 3,003,438 shares, as a passive investor on Dec 31, 2024. Filed Jan 30, 2025 (Schedule 13G/A).
- Stake
- 4.81%
- Shares
- 3,003,438
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.81% | 3,003,438 |
Source
Related
- Immunome, Inc.
- The Vanguard Group
- Immunome, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G · The Vanguard Group · Jul 29, 2025
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026